PIC Therapeutics
United States · $40.0M raised
- Headquarters
- Massachusetts
- Business Model
- B2B
- Total Funding
- $40.0M
- Last Round
- $35.0M Series AOct 2022
- Rounds
- 2
About
Biotech company developing precision therapeutics targeting oncogene protein production to treat breast cancer and other cancers.
Summary
PIC Therapeutics is a Biotech company based in United States. It has raised $40.0M in total across 2 rounds, most recently a $35.0M Series A round in Oct 2022. Investors include OrbiMed, Lumira Ventures and Advent Life Sciences.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...